share_log

Raymond James Maintains Outperform on AngioDynamics, Lowers Price Target to $10

Benzinga ·  Jan 9 05:07

Raymond James analyst Jayson Bedford maintains AngioDynamics (NASDAQ:ANGO) with a Outperform and lowers the price target from $12 to $10.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment